Nevro acquires Vyrsa Technologies for up to $75M

Nevro Corp. acquired Vyrsa Technologies, a medical device company focused on sacroiliac joint fusion devices, for $40 million at closing plus up to $35 million in milestone payments. The transaction closed on November 30, 2023.

“The acquisition of Vyrsa leverages Nevro's ability to drive long-term shareholder value by accelerating our key strategic initiatives of commercial execution, market penetration, and profit progress.”intl.nevro.com

• 1 source
• intl.nevro.comNevro Corp. - Nevro Announces Acquisition of Vyrsa™ TechnologiesNov 30, 2023

Summarized from public sources; check the original articles before acting on it.